NOVAVAX INC Quarterly Cost of Revenue in USD from Q1 2021 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Novavax Inc quarterly/annual Cost of Revenue history and growth rate from Q1 2021 to Q3 2024.
- Novavax Inc Cost of Revenue for the quarter ending September 30, 2024 was $60.6M, a 38.7% decline year-over-year.
- Novavax Inc Cost of Revenue for the twelve months ending September 30, 2024 was $321M, a 13.4% decline year-over-year.
- Novavax Inc annual Cost of Revenue for 2023 was $344M, a 61.9% decline from 2022.
- Novavax Inc annual Cost of Revenue for 2022 was $903M.
- Novavax Inc annual Cost of Revenue for 2021 was $0.000.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)